| 2-mercaptobenzothiazole | Approved Vet Approved | TNF | 7124 |
downregulated | captax results in decreased expression of TNF mRNA | 6p21.33 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | TNNT2 | 7139 |
downregulated | captax results in decreased expression of TNNT2 mRNA | 1q32.1 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | TRIM16L | 147166 |
upregulated | captax results in increased expression of TRIM16L mRNA | 17p11.2 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | TXNRD1 | 7296 |
upregulated | captax results in increased expression of TXNRD1 mRNA | 12q23.3 | |
| Carbamoylcholine | Approved | FASLG | 356 |
upregulated | [Carbachol results in increased activity of CHRM1 protein] which results in increased expression of FASLG mRNA | 1q24.3 | |
| Carbamazepine | Approved Investigational | ABCA6 | 23460 |
upregulated | Carbamazepine results in increased expression of ABCA6 mRNA | 17q24.2-q24.3 | |
| Carbamazepine | Approved Investigational | ABCB1 | 5243 |
upregulated | Carbamazepine results in increased expression of ABCB1 mRNA | 7q21.12 | |
| Carbamazepine | Approved Investigational | ABCB7 | 22 |
upregulated | Carbamazepine results in increased expression of ABCB7 mRNA | Xq13.3 | |
| Carbamazepine | Approved Investigational | ABCC2 | 1244 |
upregulated | Carbamazepine results in increased expression of ABCC2 mRNA | 10q24.2 | |
| Carbamazepine | Approved Investigational | ABCG2 | 9429 |
upregulated | Carbamazepine results in increased expression of ABCG2 mRNA | 4q22.1 | |
| Carbamazepine | Approved Investigational | ATF4 | 468 |
upregulated | Carbamazepine results in increased expression of ATF4 mRNA | 22q13.1 | |
| Carbamazepine | Approved Investigational | CCND1 | 595 |
downregulated | Carbamazepine results in decreased expression of CCND1 mRNA | 11q13.3 | |
| Carbamazepine | Approved Investigational | CYB5A | 1528 |
upregulated | Carbamazepine results in increased expression of CYB5A mRNA | 18q22.3 | |
| Carbamazepine | Approved Investigational | CYP11B2 | 1585 |
upregulated | Carbamazepine results in increased expression of CYP11B2 mRNA | 8q24.3 | |
| Carbamazepine | Approved Investigational | CYP17A1 | 1586 |
downregulated | Carbamazepine results in decreased expression of CYP17A1 mRNA | 10q24.32 | |
| Carbamazepine | Approved Investigational | CYP1A1 | 1543 |
upregulated | Carbamazepine results in increased expression of CYP1A1 mRNA | 15q24.1 | |
| Carbamazepine | Approved Investigational | CYP1A2 | 1544 |
upregulated | Carbamazepine results in increased expression of CYP1A2 mRNA | 15q24.1 | |
| Carbamazepine | Approved Investigational | CYP2A6 | 1548 |
upregulated | Carbamazepine results in increased expression of CYP2A6 mRNA | 19q13.2 | |
| Carbamazepine | Approved Investigational | CYP2B6 | 1555 |
upregulated | [Carbamazepine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA | 19q13.2 | |
| Carbamazepine | Approved Investigational | CYP2B6 | 1555 |
upregulated | [Carbamazepine results in increased activity of NR1I3 protein] which results in increased expression of CYP2B6 mRNA | 19q13.2 | |
| Carbamazepine | Approved Investigational | CYP2B6 | 1555 |
upregulated | Carbamazepine results in increased expression of CYP2B6 mRNA | 19q13.2 | |
| Carbamazepine | Approved Investigational | CYP2B7P | 1556 |
upregulated | Carbamazepine results in increased expression of CYP2B7P mRNA | 19q13.2 | |
| Carbamazepine | Approved Investigational | CYP2C19 | 1557 |
upregulated | Carbamazepine results in increased expression of CYP2C19 mRNA | 10q23.33 | |
| Carbamazepine | Approved Investigational | CYP2C8 | 1558 |
upregulated | Carbamazepine results in increased expression of CYP2C8 mRNA | 10q23.33 | |
| Carbamazepine | Approved Investigational | CYP2C9 | 1559 |
upregulated | Carbamazepine results in increased expression of CYP2C9 mRNA | 10q23.33 | |